International Development Grant
Measles and Rubella Prevention
Project Number: CA-3-M013825001
Status: Closed
Country/Region:
Maximum Contribution: $20,000,000.00
Start Date: March 27, 2013
End Date: December 31, 2014
Duration: 1.8 years
Project Description
This initiative aims to increase survival and well-being of children aged 9 months to 5 years in 3 countries at high risk of measles outbreaks. The project seeks to increase the number of children currently receiving measles vaccines and introduce measles-rubella vaccines to reduce illness and death due to rubella. Measles is one of the most contagious diseases in the world and can cause serious illness life-long disability and death. The vast majority of these deaths occur in low-income countries with weak health infrastructure. With Canada’s support the GAVI Alliance aims to strengthen the ability of health care systems to deliver routine immunizations. The governments of recipient countries lead this initiative and define the exact set of activities to be undertaken in their own countries. Project activities include purchasing vaccines; purchasing injection and cold chain equipment (needed to keep vaccines temperature-controlled until they can be delivered); training health workers; and planning implementing and assessing vaccination coverage.
Expected Results
The expected intermediate outcomes for this project include: (i) increased country ownership and leadership of measles immunization activities; and (ii) strengthened health system for routine immunization in targeted countries.
Key Information
Executing Agency:
Gavi The Vaccine Alliance
Reporting Organization:
Global Affairs Canada
Program:
YFMInternaAssistPartnershp&Programing Br
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Contributions to specific-purpose programmes and funds managed by implementing partners
Collaboration: Bilateral
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Pre-APP